Skip to main content
. 2020 Jul 28;10:1275. doi: 10.3389/fonc.2020.01275

Table 4.

Results of univariate analysis of selected prognostic factors for overall survival.

Characteristics Number of cases Number of deaths 5-year overall survival P-value (long-rank) Hazard ratio for death (95% CI) P-value (Cox)
Tobacco use
No 12 8 50.0 0.924 Reference 0.924
Yes 73 51 41.1 1.037 (0.492–2.186)
Alcohol use
No 21 16 38.1 0.343 Reference 0.345
Yes 61 40 45.9 0.756 (0.423–1.351)
Clinical tumor status
T1–T2 27 16 63.0 0.031 Reference 0.034
T3–T4 61 46 32.8 1.858 (1.049–3.291)
Clinical nodal status
N0 41 24 53.7 0.020 Reference 0.022
N+ 47 38 31.9 1.819 (1.089–3.038)
Clinical TNM stage*
Initial (I/II) 15 7 80.0 0.018 Reference 0.022
Advanced (III/IV) 73 55 34.2 2.513 (1.140–5.537)
Anatomic site
Oral cavity 69 48 44.9 0.905 Reference 0.905
Pharynx and larynx 19 14 31.6 1.037 (0.570–1.886)
Surgical margins
Negative 75 49 46.7 0.031 Reference 0.034
Positive 12 12 16.7 2.001 (1.054–3.799)
Extranodal extension
Negative (N0) 33 20 51.5 0.202 Reference
No (N+) 15 11 33.3 1.380 (0.660–2.882) 0.392
Yes (N+) 23 18 30.4 1.777 (0.938–3.367) 0.078
Perineural invasion
No 48 28 52.1 0.032 Reference 0.035
Yes 27 23 33.3 1.818 (1.043–3.169)
Vascular invasion
No 52 32 48.1 0.088 Reference 0.092
Yes 19 16 36.8 1.681 (0.919–3.073)
C228T mutation
No 82 42 16.7 0.003 Reference 0.023
Yes 6 6 52.9 2.708 (1.150–6.374)
C250T mutation
No 70 40 48.1 0.606 Reference 0.733
Yes 18 8 53.6 0.893 (0.465–1.715)
C228T or C250T mutation
No 64 45 46.9 0.445 Reference 0.446
Yes 24 17 29.2 1.243 (0.710–2.177)
*

Clinical stage according to TNM Classification of Malignant Tumors−7th ed. Bold values indicates the statistical significance (p ≤ 0.05).